Dear Editor,
We wholeheartedly agree with Tendas et al. that education on chemotherapy-induced nausea and vomiting (CINV) in bone marrow transplant (BMT) patients is important and might improve outcomes [1–4].
While we did not ask our survey participants if they took care of BMT patients, one could speculate that the 15–22 % who indicated they disagreed with the need for education on this topic were likely not involved with BMT patients [1]. Importantly, in our survey, a full 78 to 85 % of hematology/oncology physicians and nurses, respectively, indicated they either agreed or strongly agreed that education on the prevention/management of CINV in BMT is warranted.
That CINV occurs in patients undergoing BMT is reason enough to offer further education on this topic to health-care providers. We applaud the efforts of Tendas and colleagues to raise awareness of this unmet need and agree that a survey to better understand the specific education needs of clinicians who manage CINV in the BMT setting would be beneficial.
References
Van Laar ES, Desai JM, Jatoi A (2015) Professional educational needs for chemotherapy-induced nausea and vomiting (CINV): multinational survey results from 2,388 health care providers. Support Care Cancer 23(1):151–157
Tendas A, Sollazzo F, Bruno A, Cupelli L, Niscola P, Pignatelli AC, Dentamaro T, de Fabritiis P, Arcese W (2012) Obstacles to managing chemotherapy-induced nausea and vomiting in high-dose chemotherapy with stem cell transplant. Support Care Cancer 20(5):891–892
Tendas A, Sollazzo F, Niscola P, Cupelli L, Carlo C, Mauroni MR et al (2012) Management of chemotherapy-induced nausea and vomiting in adults patients after haematopoietic stem cell transplantation: adherence to guidelines and costs analysis from the quality of life working party of the Rome transplant network. Bone Marrow Transplant 47:S467–S467
Einhorn LH, Grunberg SM, Rapoport B, Rittenberg C, Feyer P (2011) Antiemetic therapy for multiple-day chemotherapy and additional topics consisting of rescue antiemetics and high-dose chemotherapy with stem cell transplant: review and consensus statement. Support Care Cancer 19(Suppl 1):S1–S4
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Van Laar, E.S., Desai, J.M. & Jatoi, A. Response. Support Care Cancer 23, 2213 (2015). https://doi.org/10.1007/s00520-015-2753-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00520-015-2753-2